Liver histology as a predictor of the response to interferon therapy
Okuno, T.; Arai, K.; Shindo, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 1): 975-980
1995
ISSN/ISBN: 0047-1852 PMID: 7563913 Document Number: 439713
Document emailed within 1 workday
Related Documents
Derbala, M.F.; Amer, A.M.; El Defrawi, I.E. 2006: Anti-HCV IgM as predictor of response to interferon therapy in schistosomal patients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(1): 44Xu, D.-Z.; Xie, Y.; Li, Z.-Q. 2005: Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 550-553
Ciatto, S.; Pacini, P.; Confortini, M.; Massimo, V. 1994: Reliability of immunocytochemical assay of estrogen receptors on breast cancer aspirates as a predictor of clinical response to hormone therapy Acta Cytologica 38(4): 666-667
Herman, R.; Sładek, M.łg.; Pieczarkowski, S.ła.; Dumnicka, P.; Fyderek, K. 2017: Is mean platelet volume a good predictor of sustained response to one year infliximab therapy in pediatric patients with Crohn's disease? Folia Medica Cracoviensia 57(2): 63-71
Kristian, P.; Schreter, I.; Siegfried, L.; Jarcuska, P.; Jarcuska, P.; Paralicova, Z.; Porubcin, S. 2010: Impact of TTV and SENV infection in chronic hepatitis B or C on liver histology and therapy outcome Bratislavske Lekarske Listy 111(12): 629-634
Awan, A.; Umar, M.; Khaar, H.tul.Bushra.; Kulsoom, A.; Minhas, Z.; Ambreen, S.; Habib, N.; Mumtaz, W.; Habib, F. 2016: Predictive Value of Early Viriological Response for Sustained Viriological Response in Chronic Hepatitis with Conventional Interferon Therapy Journal of Ayub Medical College Abbottabad: Jamc 28(1): 14-17
Bogdal, J.; Cichecka, K.; Kirchmayer, S.; Mika, M.; Tarnawski, A. 1976: Immunoglobulins in chronic alcoholics: relation to liver histology and effect of 2-month abstinence therapy Archivum Immunologiae et Therapiae Experimentalis 24(6): 799-805
Panasiuk, A.; Prokopowicz, D.; Zak, J. 2004: Immunological response in chronic hepatitis C virus infection during interferon alpha therapy Hepato-Gastroenterology 51(58): 1088-1092
Tang, X.; Xu, Y.; Yuan, X. 2001: Relationship between intrahepatic HCV-specific CTL activity and response to interferon therapy in chronic hepatitis C Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 15(4): 352-354
Van Thiel, D.H.; Wright, H.I.; Gavaler, J.S.; Fung, J.; Starzl, T.E. 1991: Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine Transplantation Proceedings 23(6): 3052-3053
Rao, H-ying.; Wei, L.; Li, J.; Zhang, L-fang.; Chen, H-yong.; Zhu, L-min.; Liu, F.; Sun, Y.; Wang, H. 2009: Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response Hepato-Gastroenterology 56(90): 328-334
Acaba, L.; Mangual, A.; Vélez García, E. 2000: Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin e levels Boletin de la Asociacion Medica de Puerto Rico 92(4-8): 59-62
Korenaga, M.; Hino, K.; Okita, K. 2001: A possible role of human leukocyte antigen(HLA) typing for predicting response to interferon therapy in chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 59(7): 1345-1350
Asim, M.; Rashid, A.; Khan, A. 2018: Interferon alpha receptors and STAT1 as therapy predictors of a sustained virological response in hepatitis C/B co-infection JPMA. Journal of the Pakistan Medical Association 68(11): 1446-1450
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Arase, Y. 2015: Prolonged maintenance therapy by low dose interferon for HCV patients with chronic liver disease Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 284-289
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Di Costanzo, G.G.; Ascione, A.; Lanza, A.G.; De Luca, M.; Bracco, A.; Lojodice, D.; Marsilia, G.M.; Ferbo, U. 1996: Resistance to alpha interferon therapy in HCV chronic liver disease: role of hepatic fibrosis Italian Journal of Gastroenterology 28(3): 140-146
Srivastava, S.; Bertagnolli, M.; Lewis, J.H. 2005: Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic Journal of the National Medical Association 97(12): 1703-1707
Ohnishi, K.; Nomura, F.; Nakano, M. 1991: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status American Journal of Gastroenterology 86(8): 1041-1049